{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:17:57Z","timestamp":1762521477976,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with glioma (PwG), a type of brain tumour, have an elevated risk of developing venous thromboembolism (VTE). When VTE occurs, anticoagulant therapy is typically initiated, and in some cases, it may be prescribed prophylactically. However, these patients are also at risk of intracranial haemorrhage (ICH) as a complication of anticoagulation. Despite the clinical importance of this risk-benefit balance, it remains unclear whether predictive tools exist to guide anticoagulation decisions in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a scoping review to determine whether predictive models exist for estimating the risk of intracranial haemorrhage (ICH) in people with glioma (PwG) receiving anticoagulant therapy. For any models identified, we assessed their methodological quality and predictive performance. Our search included MEDLINE, EMBASE (via Ovid), and the Cochrane Library, covering publications up to 29 November 2024. Studies were eligible if they employed predictive modelling to assess ICH risk in anticoagulated PwG. Two reviewers independently screened studies and extracted data. We used the PROBAST tool to evaluate model quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 1,585 articles screened, none met the inclusion criteria. Although some studies reported on ICH risk in PwG, none developed or validated predictive models tailored to this clinical context. One excluded study provides conceptual insights that may inform future modelling efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The absence of these models underscores a critical gap in neuro-oncology research and highlights the urgent need for targeted model development to support anticoagulation decision-making in PwG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-025-04461-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:10:22Z","timestamp":1762521022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence gap in predicting intracranial haemorrhage risk in people with glioma on anticoagulants: a scoping review"],"prefix":"10.1186","volume":"25","author":[{"given":"Taofiq Adedeji","family":"Adeyemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Greenley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzana","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Maraveyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Stephen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"25","key":"4461_CR1","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1182\/blood-2017-02-767285","volume":"129","author":"C Mantia","year":"2017","unstructured":"Mantia C, et al. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. 2017;129(25):3379\u201385.","journal-title":"Blood"},{"issue":"7","key":"4461_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"issue":"8","key":"4461_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.2005.04.6656","volume":"24","author":"DE Gerber","year":"2006","unstructured":"Gerber DE, Grossman SA, Streiff MB. Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol. 2006;24(8):1310\u20138.","journal-title":"J Clin Oncol"},{"issue":"suppl5","key":"4461_CR4","first-page":"v181","volume":"16","author":"MN Khoury","year":"2014","unstructured":"Khoury MN, et al. Ql-15a: A retrospective analysis of intracranial hemorrhage in patients receiving anticoagulation for venous thromboembolism in the setting of glioblastoma. Neurooncology. 2014;16(suppl5):v181\u2013181.","journal-title":"Neurooncology"},{"issue":"6","key":"4461_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1638","volume":"10","author":"A Porfidia","year":"2020","unstructured":"Porfidia A, et al. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: a meta-analysis. Brain Behav. 2020;10(6):e01638.","journal-title":"Brain Behav"},{"issue":"2","key":"4461_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-015-1840-z","volume":"124","author":"MB Streiff","year":"2015","unstructured":"Streiff MB, et al. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors. J Neurooncol. 2015;124(2):299\u2013305.","journal-title":"J Neurooncol"},{"issue":"Supplement6","key":"4461_CR7","first-page":"vi138","volume":"21","author":"D Unruh","year":"2019","unstructured":"Unruh D, et al. InnV-42: venous thromboembolism risk assessment in patients with glioma. Neurooncology. 2019;21(Supplement6):vi138\u2013138.","journal-title":"Neurooncology"},{"issue":"4","key":"4461_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/labinvest.3700070","volume":"84","author":"DJ Brat","year":"2004","unstructured":"Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest. 2004;84(4):397\u2013405.","journal-title":"Lab Invest"},{"issue":"12","key":"4461_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1101\/gad.192351.112","volume":"26","author":"C D\u2019Souza-Schorey","year":"2012","unstructured":"D\u2019Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012;26(12):1287\u201399.","journal-title":"Genes Dev"},{"key":"4461_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/TA.0000000000000556","volume":"78","author":"LN Godat","year":"2015","unstructured":"Godat LN, et al. Can we ever stop worrying about venous thromboembolism after trauma? J Trauma Acute Care Surg. 2015;78:475\u201381.","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"4461_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/rth2.12377","volume":"4","author":"BJ Carney","year":"2020","unstructured":"Carney BJ, et al. Anticoagulation after intracranial hemorrhage in brain tumors: risk of recurrent hemorrhage and venous thromboembolism. Res Pract Thromb Haemost. 2020;4(5):860\u20135.","journal-title":"Res Pract Thromb Haemost"},{"key":"4461_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030643","author":"A Qdaisat","year":"2022","unstructured":"Qdaisat A, et al. Characteristics and outcomes of intracranial hemorrhage in cancer patients visiting the emergency department. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11030643.","journal-title":"J Clin Med"},{"issue":"9","key":"4461_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/jth.13387","volume":"14","author":"JI Zwicker","year":"2016","unstructured":"Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost. 2016;14(9):1736\u201340.","journal-title":"J Thromb Haemost"},{"issue":"Supplement3","key":"4461_CR14","doi-asserted-by":"publisher","first-page":"iii7","DOI":"10.1093\/noajnl\/vdad070.027","volume":"5","author":"S Jagasia","year":"2023","unstructured":"Jagasia S, Krauze A. Clrm-04: developing a word lexicon for venous thromboembolism data annotation using radiology reports in glioblastoma patients\u2014linking large-scale data sets to expand clinical features for AI. Neuro-Oncol Adv. 2023;5(Supplement3):iii7-8.","journal-title":"Neuro-Oncol Adv"},{"issue":"3","key":"4461_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11060-024-04574-w","volume":"166","author":"P Dasgupta","year":"2024","unstructured":"Dasgupta P, Rousseau JF. Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma. J Neurooncol. 2024;166(3):569\u201374.","journal-title":"J Neurooncol"},{"key":"4461_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2025.111041","author":"AK Jain","year":"2025","unstructured":"Jain AK, et al. Low-grade gliomas presenting with hemorrhage: are intratumoral blood products associated with malignant transformation? J Clin Neurosci. 2025. https:\/\/doi.org\/10.1016\/j.jocn.2025.111041.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"4461_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-0039-1687892","volume":"45","author":"AL Czap","year":"2019","unstructured":"Czap AL, Becker A, Wen PY. Thrombotic complications in gliomas. Semin Thromb Hemost. 2019;45(4):326\u201333.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"4461_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.23736\/S0390-5616.21.05536-3","volume":"67","author":"A Bianconi","year":"2023","unstructured":"Bianconi A, et al. Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives. J Neurosurg Sci. 2023;67(2):236\u201340.","journal-title":"J Neurosurg Sci"},{"key":"4461_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/CCO.0000000000000226","volume":"27","author":"S Taillibert","year":"2015","unstructured":"Taillibert S, Taillandier L, Le Rhun \u00c9. Venous thrombosis in patients with high-grade glioma. Curr Opin Oncol. 2015;27:516\u201321.","journal-title":"Curr Opin Oncol"},{"key":"4461_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","volume":"50","author":"K Talari","year":"2020","unstructured":"Talari K, Goyal M. Retrospective studies \u2013 utility and caveats. J R Coll Physicians Edinb. 2020;50:398\u2013402.","journal-title":"J R Coll Physicians Edinb"},{"key":"4461_CR21","doi-asserted-by":"publisher","unstructured":"D\u2019Asti E, Fang Y, Rak J. Brain neoplasms and Coagulation\u2014Lessons from heterogeneity. Rambam Maimonides Med J, 2014. 5 (4):e0030. https:\/\/doi.org\/10.5041\/RMMJ.10164.","DOI":"10.5041\/RMMJ.10164"},{"issue":"4","key":"4461_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1634\/theoncologist.2017-0274","volume":"23","author":"RJ Lin","year":"2018","unstructured":"Lin RJ, Green DL, Shah GL. Therapeutic anticoagulation in patients with primary brain tumors or secondary brain metastasis. Oncologist. 2018;23(4):468\u201373.","journal-title":"Oncologist"},{"key":"4461_CR23","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1182\/bloodadvances.2020003238","volume":"4 24","author":"A Leader","year":"2020","unstructured":"Leader A, et al. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases. Blood Adv. 2020;4 24:6291\u20137.","journal-title":"Blood Adv"},{"issue":"9","key":"4461_CR24","doi-asserted-by":"publisher","DOI":"10.3310\/hta21090","volume":"21","author":"JAC Sterne","year":"2017","unstructured":"Sterne JAC, et al. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2017;21(9):438.","journal-title":"Health Technol Assess"},{"key":"4461_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1785482","author":"AH El-Sherbini","year":"2024","unstructured":"El-Sherbini AH, et al. Machine learning as a diagnostic and prognostic tool for predicting thrombosis in cancer patients: a systematic review. Semin Thromb Hemost. 2024. https:\/\/doi.org\/10.1055\/s-0044-1785482.","journal-title":"Semin Thromb Hemost"},{"key":"4461_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225284","author":"M Feehan","year":"2021","unstructured":"Feehan M, et al. Artificial intelligence, heuristic biases, and the optimization of health outcomes: cautionary optimism. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10225284.","journal-title":"J Clin Med"},{"key":"4461_CR27","doi-asserted-by":"crossref","unstructured":"Luo J et al. Emerging Role of Artificial Intelligence in Diagnosis, Classification and Clinical Management of Glioma. Seminars in cancer biology, 2023.","DOI":"10.1016\/j.semcancer.2023.03.006"},{"key":"4461_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hcs2.55","volume":"2","author":"SK Townsley","year":"2023","unstructured":"Townsley SK, et al. Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning. Health Care Science. 2023;2:205\u201322.","journal-title":"Health Care Science"},{"key":"4461_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.784455","author":"M Mart\u00ednez-Garc\u00eda","year":"2022","unstructured":"Mart\u00ednez-Garc\u00eda M, Hern\u00e1ndez-Lemus E. Data integration challenges for machine learning in precision medicine. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2021.784455.","journal-title":"Front Med"},{"issue":"7","key":"4461_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, et al. Prisma extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4461_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4461_CR32","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","volume":"170","author":"KGM Moons","year":"2019","unstructured":"Moons KGM, et al. PROBAST: A tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1\u201333.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4461_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ, et al. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban. Stroke. 2014;45(5):1304\u201312.","journal-title":"Stroke"},{"issue":"11","key":"4461_CR34","doi-asserted-by":"publisher","first-page":"13521","DOI":"10.1007\/s10462-023-10466-8","volume":"56","author":"SF Ahmed","year":"2023","unstructured":"Ahmed SF, et al. Deep learning modelling techniques: current progress, applications, advantages, and challenges. Artif Intell Rev. 2023;56(11):13521\u2013617.","journal-title":"Artif Intell Rev"},{"key":"4461_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bodyim.2022.01.013","volume":"41","author":"D Liang","year":"2022","unstructured":"Liang D, et al. Examining the utility of nonlinear machine learning approaches versus linear regression for predicting body image outcomes: the U.S. body project I. Body Image. 2022;41:32\u201345.","journal-title":"Body Image"},{"key":"4461_CR36","doi-asserted-by":"publisher","DOI":"10.37394\/23209.2024.21.29","author":"M Ro\u017eman","year":"2024","unstructured":"Ro\u017eman M, Ki\u0161i\u0107 A, Ore\u0161ki D. Comparative analysis of nonlinear models developed using machine learning algorithms. WSEAS Trans Inf Sci Appl. 2024. https:\/\/doi.org\/10.37394\/23209.2024.21.29.","journal-title":"WSEAS Trans Inf Sci Appl"},{"issue":"4","key":"4461_CR37","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s11831-023-09898-w","volume":"30","author":"SS Kshatri","year":"2023","unstructured":"Kshatri SS, Singh D. Convolutional neural network in medical image analysis: a review. Arch Comput Methods Eng. 2023;30(4):2793\u2013810.","journal-title":"Arch Comput Methods Eng"},{"key":"4461_CR38","doi-asserted-by":"crossref","unstructured":"Zeng LR. Segmentation of Medical Image Based on U-Net Neural Network. Proceedings of the 2024 9th International Conference on Biomedical Imaging, Signal Processing, 2024.","DOI":"10.1145\/3707172.3707181"},{"key":"4461_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13286","author":"G Samarasinghe","year":"2021","unstructured":"Samarasinghe G, et al. Deep learning for segmentation in radiation therapy planning: a review. J Med Imaging Radiat Oncol. 2021. https:\/\/doi.org\/10.1111\/1754-9485.13286.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"12","key":"4461_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/annrheumdis-2021-220454","volume":"80","author":"SJW Shoop-Worrall","year":"2021","unstructured":"Shoop-Worrall SJW, et al. Nothing about Us without Us: involving patient collaborators for machine learning applications in rheumatology. Ann Rheum Dis. 2021;80(12):1505\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4461_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01582-1","volume":"18","author":"P Cocco","year":"2020","unstructured":"Cocco P, et al. Target product profiles for medical tests: a systematic review of current methods. BMC Med. 2020;18(1):119.","journal-title":"BMC Med"},{"issue":"3","key":"4461_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4103\/crst.crst_250_23","volume":"7","author":"G Bijalwan","year":"2024","unstructured":"Bijalwan G, et al. Glioblastoma multiforme - a rare type of cancer: A narrative review. Cancer Res Stat Treat. 2024;7(3):340\u201351.","journal-title":"Cancer Res Stat Treat"},{"key":"4461_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081349","author":"C De Luca","year":"2022","unstructured":"De Luca C, et al. Regional development of glioblastoma: the anatomical conundrum of cancer biology and its surgical implication. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11081349.","journal-title":"Cells"},{"key":"4461_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1202170","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Heterogeneity matching and IDH prediction in adult-type diffuse gliomas: a DKI-based habitat analysis. Front Oncol. 2023;13:1202170.","journal-title":"Front Oncol"},{"key":"4461_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.109638","volume":"187","author":"LA Cox","year":"2020","unstructured":"Cox LA. Implications of nonlinearity, confounding, and interactions for estimating exposure concentration-response functions in quantitative risk analysis. Environ Res. 2020;187:109638\u2013109638.","journal-title":"Environ Res"},{"key":"4461_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1160\/TH14-12-1036","volume":"113","author":"CM Hillis","year":"2015","unstructured":"Hillis CM, Crowther MA. Acute phase treatment of VTE: anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2015;113:1193\u2013202.","journal-title":"Thromb Haemost"},{"key":"4461_CR47","doi-asserted-by":"crossref","unstructured":"Barnes G, Malik A, Ha N. Choice and Duration of Anticoagulation for Venous Thromboembolism. 2023.","DOI":"10.20944\/preprints202312.1080.v1"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04461-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:10:24Z","timestamp":1762521024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04461-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}